[Ip-health] WHA Side Event: GHIT Innovative Financing for Global Health R&D

Jaya Banerji banerjij at mmv.org
Thu May 16 06:53:20 PDT 2013


The Ministry of Health, Labour and Welfare of Japan
&
Global Health Innovative Technology (GHIT) Fund

Cordially invite you to attend a side event to the World Health Assembly entitled:

Innovative Financing for Global Health R&D:
Global Health Experts Comment on Japan's First Public-Private Partnership to Advance Global Health R&D

Date: Friday, 24 May 2013 at 12.45 - 14.15

Venue: Room XXIV of Palais des Nations, Geneva

----Lunch will be provided----

Agenda is as follows:

George Jagoe, MBA, Moderator
Executive Vice President for Access and Product Management, Medicines for Malaria Venture

OPENING REMARKS
Masato Mugitani, MD, MPH
Assistant Minister for Global Health, Ministry of Health, Labour and Welfare, Japan

PANEL
BT Slingsby, MD, PhD, MPH
Executive Director & CEO, Global Health Innovative Technology Fund

Bernard Pécoul, MD, MPH
Executive Director, Drugs for Neglected Disease initiative

David Reddy, PhD
CEO, Medicines for Malaria Venture

The Global Health Innovative Technology Fund (GHIT Fund), launched on 8 April 2013, is bringing Japanese leadership in health and technology innovation - from its public and private sectors - to the global fight against diseases that disproportionately affect the poorest of the poor. Read more at http://www.mmv.org/newsroom/press-releases/japan%E2%80%99s-first-ppp-spearhead-innovation-in-global-health


NB: All attendees have to pass through security at the entrance to the Palais des Nations



Jaya Banerji | Medicines for Malaria Venture
Director Communications and Advocacy
T: +41 22 799 4071 | M: +41 79 707 7181
Email: banerjij at mmv.org<mailto:banerjij at mmv.org>

Defeating Malaria Together | www.mmv.org<http://www.mmv.org/>

________________________________
This email and any attachments may contain confidential information. If you are not the intended recipient, please delete the email and any attachments and notify the sender immediately.
________________________________




More information about the Ip-health mailing list